育龄中期的抗苗勒管激素与中年骨密度及骨转换标志物的关联
在美国纵向队列450名经产女性中,2003-2006年(平均37.0岁)测血浆抗苗勒管激素(AMH),2017-2021年(平均51.0岁)测骨密度及骨转换标志物。与AMH>3.5 ng/mL者相比,AMH<1.0 ng/mL者随访时脊柱、髋部骨密度较低,PINP和CTX-I较高。育龄中期AMH较低与约14年后较低骨密度和较高骨转换相关。
要点
- 育龄中期AMH<1.0 ng/mL者随访时脊柱骨密度较AMH>3.5 ng/mL者低0.06 g/cm2。
- AMH<1.0 ng/mL者随访时PINP高0.36 SD、CTX-I高0.34 SD(均以SD为单位)。
- AMH与骨密度的关联主要由随访时绝经状态介导。
核心结论
- 育龄中期AMH较低与约14年后较低骨密度和较高骨转换相关。
- 作者认为育龄中期卵巢储备可能是长期骨健康的有价值预测指标。
研究设计与样本
- 美国纵向队列研究,纳入450名经产女性(71%为白人)。
- 2003-2006年测血浆AMH(平均37.0岁,SD 5.1),2017-2021年测骨密度(平均51.0岁,SD 5.1)。
- 骨密度用双能X线吸收法测脊柱、髋部和股骨颈;次要结局为血浆PINP和CTX-I。
主要发现
- 校正人口学和生活方式后,与AMH>3.5 ng/mL者相比,AMH<1.0 ng/mL者随访时脊柱骨密度低0.06 g/cm2(95%CI -0.10至-0.02)、髋部低0.05 g/cm2(95%CI -0.08至-0.02)、股骨颈低0.03 g/cm2(95%CI -0.06至0.00)。
- 与AMH>3.5 ng/mL者相比,AMH<1.0 ng/mL者PINP高0.36 SD(95%CI 0.10至0.63)、CTX-I高0.34 SD(95%CI 0.07至0.60)。
- AMH与脊柱骨密度的关联在绝经后女性中更明显,而与骨转换标志物的关联在尚未绝经的女性中更明显。
- AMH与骨密度的关联主要由随访时绝经状态介导。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The concentration of circulating anti-Müllerian hormone (AMH) predicts short-term (3-5 years) bone loss around menopause. Whether AMH during midreproductive years predicts bone health over a decade later is unknown. OBJECTIVE: To study the association of AMH levels in midreproductive years with bone density and turnover biomarkers measured after ∼14 years of follow-up. METHODS: We assessed plasma AMH in 2003-2006 (mean 37.0 years, SD 5.1) among 450 parous women (71% White) in a US longitudinal cohort, and bone mineral density (BMD; spine, hip, and femoral neck, measured by dual-energy X-ray absorptiometry) in 2017-2021 (mean 51.0 years, SD 5.1). Secondary outcomes were plasma levels of procollagen type I N-propeptide (PINP) and type I collagen cross-linked C telopeptide (CTX-I). RESULTS: In linear regression models adjusted for demographics and lifestyle, compared with women with AMH >3.5 ng/mL, those with AMH <1.0 ng/mL had lower BMD (g/cm2) at follow-up (beta [95% CI] spine: -.06 [-0.10, -0.02]; hip: -.05 [-0.08, -0.02]; femoral neck: -.03 [-0.06, 0.00]) and higher bone turnover markers (beta [95% CI] PINP: .36 SD [0.10, 0.63]; CTX-I: .34 SD [0.07, 0.60]). The association of AMH with spine BMD was more pronounced among postmenopausal women in contrast to associations with bone turnover markers, which were more pronounced among women who had not yet reached menopause. The associations between AMH and BMD were primarily mediated by menopausal status at follow-up. CONCLUSION: Lower AMH during midreproductive years is associated with lower BMD and higher bone turnover 14 years later. Ovarian reserve during midreproductive years may be a valuable predictor of long-term bone health.
引用
- Wang S, Yu EW, Hivert MF, et al. Associations of AMH in Midreproductive Years with Bone Mineral Density and Turnover Markers in Midlife. J Clin Endocrinol Metab. 2025. PMID: 39418391. doi:10.1210/clinem/dgae694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。